Hypertension
Is there a Role of Anti-platelet Aggregation Agents in the Management of Primary Hypertension: An In-Vivo Study
Introduction:
Hypertension is a leading identifiable and reversible risk factor for myocardial infarction, heart failure, atrial fib...
Hypertension risk in sexual and gender minority individuals
Editorial
Expert Rev Cardiovasc Ther
. 2022 May 9.
doi: 10.1080/14779072.2022.2075345.
Online ahe...
Prevalence, Treatment, and Control of Hypertension Among US Women of Reproductive Age by Race/Hispanic Origin
Background:
To explore the prevalence, pharmacologic treatment, and control of hypertension among US non-pregnant women of reproduct...
Prevalence, Treatment, and Control of Hypertension Among US Women of Reproductive Age by Race/Hispanic Origin | American Journal of Hypertension
Nicole D Ford, Cheryl L Robbins, Donald K Hayes, Jean Y Ko, Fleetwood Loustalot, Prevalence, Treatment, and Control of Hypertension Among US Women...
Racial and Ethnic Equity in Care for Hypertension and Diabetes in an Urban Indian Health Organization
J Racial Ethn Health Disparities
. 2022 May 3.
doi: 10.1007/s40615-022-01317-3.
Online ahead of print.
...
The Association of N-Terminal Pro-Brain Natriuretic Peptide With Time to Clinical Worsening in Hispanic Patients With Pulmonary Arterial Hypertension
Background:
Measurement of N-terminal pro-brain natriuretic peptide (NT-proBNP) level is an important parameter in the risk assessme...
Trending Topics
Features
- Drive Toolkit
Download and distribute powerful vaccination QI resources for your community.
- Health Champions
Sign up now to support health equity and sustainable health outcomes in your community.
- Cancer Early Detection
MCED tests use a simple blood draw to screen for many kinds of cancer at once.
- PR
FYHN is a bridge connecting health information providers to BIPOC communities in a trusted environment.
- Medicare
Discover an honest look at our Medicare system.
- Alliance for Representative Clinical Trials
ARC was launched to create a network of community clinicians to diversify and bring clinical trials to communities of color and other communities that have been underrepresented.
- Reducing Patient Risk
The single most important purpose of our healthcare system is to reduce patient risk for an acute event.
